Concizumab Novo Nordisk - Search News

News

Novo Nordisk to sell Wegovy through telehealth firms

Zacks Investment Research on M… · 5d

Novo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock?

Novo Nordisk NVO shares have lost 16.7%, attributable to both sector-specific developments and broader macroeconomic headwinds. A key catalyst was last week’s announcement from rival Eli Lilly LLY, which reported first phase III success for its oral GLP-1 candidate,

The Hill on MSN · 5h

Novo Nordisk partners with Ro, Hims and LifeMD to sell low-cost Wegovy

Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer, lower cost version of its popular weight-loss drug Wegovy. The pharmaceutical company announced it would

The Wall Street Journal on MSN · 11h

Hims & Hers to Sell Novo Nordisk’s Wegovy in U.S., Shares Soar

Him & Hers Health and Novo Nordisk are collaborating to offer weight-loss treatment, including access to Wegovy along with other services to treat obesity.

4d

Novo Nordisk Wins Legal Battle To Curb Unsafe Knockoff Versions Of Ozempic, Wegovy

The court ruled in favor of Novo Nordisk and the FDA, rejecting a compounding pharmacy group's attempt to stop the FDA's ...

NBC Los Angeles4d

Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...

22d

Novo Nordisk to invest $1.09 billion to boost Ozempic, Wegovy production in Brazil

Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results